Dana-Farber Cancer Institute shared on LinkedIn:
“Researchers Stephanie Dougan, and Edward Chouchani, joined President and CEO of Dana-Farber Cancer Institute, Benjamin L. Ebert, at a special event in New York City. Together they discussed how our unique bench-to-bedside environment accelerates the translation of discoveries into clinical advances.
‘At Dana-Faber, the discovery and basic science departments are embedded in clinical operations. That is something you don’t normally see. At most institutions, these areas are like two ships passing in the night. The collaboration you see happening at Dana-Farber between these departments has fundamentally reshaped the direction of our research. Everybody at Dana-Farber is always putting their minds together to say ‘how are we going to come together with our individual expertise and really make a difference in this disease?’ Dana-Farber is an incredibly exciting and intellectually stimulating place to be. You feel the forward progress we’re making in changing the future of cancer care and research every day.’
— Chouchani
Philanthropy fuels our leadership in discovery science – giving researchers like Dougan and Chouchani the freedom to pursue bold ideas and accelerate progress for patients.
We’re grateful to the generous community that makes this work possible.”